Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Chloroquin | Research

Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds

Authors: Awet Alem Teklemichael, Shusaku Mizukami, Kazufumi Toume, Farhana Mosaddeque, Mohamed Gomaa Kamel, Osamu Kaneko, Katsuko Komatsu, Juntra Karbwang, Nguyen Tien Huy, Kenji Hirayama

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

Herbal medicine has been a rich source of new drugs exemplified by quinine and artemisinin. In this study, a variety of Japanese traditional herbal medicine (‘Kampo’) were examined for their potential anti-malarial activities.

Methods

A comprehensive screening methods were designed to identify novel anti-malarial drugs from a library of Kampo herbal extracts (n = 120) and related compounds (n = 96). The anti-malarial activity was initially evaluated in vitro against chloroquine/mefloquine-sensitive (3D7) and-resistant (Dd2) strains of Plasmodium falciparum. The cytotoxicity was also evaluated using primary adult mouse brain cells. After being selected through the first in vitro assay, positive extracts and compounds were examined for possible in vivo anti-malarial activity.

Results

Out of 120 herbal extracts, Coptis rhizome showed the highest anti-malarial activity (IC50 1.9 µg/mL of 3D7 and 4.85 µg/mL of Dd2) with a high selectivity index (SI) > 263 (3D7) and > 103 (Dd2). Three major chlorinated compounds (coptisine, berberine, and palmatine) related to Coptis rhizome also showed anti-malarial activities with IC50 1.1, 2.6, and 6.0 µM (against 3D7) and 3.1, 6.3, and 11.8 µM (against Dd2), respectively. Among them, coptisine chloride exhibited the highest anti-malarial activity (IC50 1.1 µM against 3D7 and 3.1 µM against Dd2) with SI of 37.8 and 13.2, respectively. Finally, the herbal extract of Coptis rhizome and its major active compound coptisine chloride exhibited significant anti-malarial activity in mice infected with Plasmodium yoelii 17X strain with respect to its activity on parasite suppression consistently from day 3 to day 7 post-challenge. The effect ranged from 50.38 to 72.13% (P < 0.05) for Coptis rhizome and from 81 to 89% (P < 0.01) for coptisine chloride.

Conclusion

Coptis rhizome and its major active compound coptisine chloride showed promising anti-malarial activity against chloroquine-sensitive (3D7) and -resistant (Dd2) strains in vitro as well as in vivo mouse malaria model. Thus, Kampo herbal medicine is a potential natural resource for novel anti-malarial agents.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO. World malaria report 2019. Geneva: World Health Organization; 2019. WHO. World malaria report 2019. Geneva: World Health Organization; 2019.
2.
go back to reference Wilson KL, Flanagan KL, Prakash MD, Plebanski M. Malaria vaccines in the eradication era: current status and future perspectives. Expert Rev Vaccines. 2019;18:133–51.PubMedCrossRef Wilson KL, Flanagan KL, Prakash MD, Plebanski M. Malaria vaccines in the eradication era: current status and future perspectives. Expert Rev Vaccines. 2019;18:133–51.PubMedCrossRef
3.
go back to reference Zucca M, Scutera S, Savoia D. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases. Curr Med Chem. 2013;20:502–26.PubMed Zucca M, Scutera S, Savoia D. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases. Curr Med Chem. 2013;20:502–26.PubMed
4.
go back to reference Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov. 2004;3:509–20.PubMedCrossRef Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov. 2004;3:509–20.PubMedCrossRef
5.
go back to reference Mnzava AP, Macdonald MB, Knox TB, Temu EA, Shiff CJ. Malaria vector control at a crossroads: public health entomology and the drive to elimination. Trans R Soc Trop Med Hyg. 2014;108:550–4.PubMedCrossRef Mnzava AP, Macdonald MB, Knox TB, Temu EA, Shiff CJ. Malaria vector control at a crossroads: public health entomology and the drive to elimination. Trans R Soc Trop Med Hyg. 2014;108:550–4.PubMedCrossRef
6.
go back to reference Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol. 1997;27:231–40.PubMedCrossRef Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol. 1997;27:231–40.PubMedCrossRef
7.
go back to reference Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.PubMedPubMedCentralCrossRef Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.PubMedPubMedCentralCrossRef
8.
go back to reference Monjol BE, Useh MF. Detection of Plasmodium falciparum chloroquine resistance transporter (PfCRT) mutant gene amongst malaria-infected pregnant women in Calabar, Nigeria. Ann Parasitol. 2017;63:323–30.PubMed Monjol BE, Useh MF. Detection of Plasmodium falciparum chloroquine resistance transporter (PfCRT) mutant gene amongst malaria-infected pregnant women in Calabar, Nigeria. Ann Parasitol. 2017;63:323–30.PubMed
9.
go back to reference Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today. 1987;3:241–6.PubMedCrossRef Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today. 1987;3:241–6.PubMedCrossRef
11.
go back to reference Sowunmi A, Akano K, Ntadom G, Ayede AI, Ibironke FO, Aderoyeje T, et al. Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria-associated anaemia in Nigerian children during seven years of adoption as first-line treatments. Infect Dis Poverity. 2017;6:36.CrossRef Sowunmi A, Akano K, Ntadom G, Ayede AI, Ibironke FO, Aderoyeje T, et al. Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria-associated anaemia in Nigerian children during seven years of adoption as first-line treatments. Infect Dis Poverity. 2017;6:36.CrossRef
13.
go back to reference Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337–45.PubMedPubMedCentralCrossRef Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337–45.PubMedPubMedCentralCrossRef
14.
go back to reference Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491–7.PubMedPubMedCentralCrossRef Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491–7.PubMedPubMedCentralCrossRef
15.
go back to reference Li F-S, Weng J-K. Demystifying traditional herbal medicine with modern approach. Nat Plants. 2017;3:17109.PubMedCrossRef Li F-S, Weng J-K. Demystifying traditional herbal medicine with modern approach. Nat Plants. 2017;3:17109.PubMedCrossRef
16.
go back to reference Norn S, Permin H, Kruse PR, Kruse E. From willow bark to acetylsalicylic acid. Dan Medicinhist Arbog. 2009;37:79–98 (in Danish).PubMed Norn S, Permin H, Kruse PR, Kruse E. From willow bark to acetylsalicylic acid. Dan Medicinhist Arbog. 2009;37:79–98 (in Danish).PubMed
17.
go back to reference Whayne TF. Clinical use of digitalis: a state of the art review. Am J Cardiovasc Drug. 2018;18:427–40.CrossRef Whayne TF. Clinical use of digitalis: a state of the art review. Am J Cardiovasc Drug. 2018;18:427–40.CrossRef
18.
go back to reference Norn S, Kruse PR, Kruse E. History of opium poppy and morphine. Dan Medicinhist Arbog. 2005;33:171–84 (in Danish).PubMed Norn S, Kruse PR, Kruse E. History of opium poppy and morphine. Dan Medicinhist Arbog. 2005;33:171–84 (in Danish).PubMed
19.
21.
go back to reference Permin H, Norn S, Kruse E, Kruse PR. On the history of Cinchona bark in the treatment of malaria. Dan Medicinhistorisk Arbog. 2016;44:9–30. Permin H, Norn S, Kruse E, Kruse PR. On the history of Cinchona bark in the treatment of malaria. Dan Medicinhistorisk Arbog. 2016;44:9–30.
23.
go back to reference Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I. Evaluating Cinchona bark and quinine for treating and preventing malaria. J Roy Soc Med. 2017;110:73–82.PubMedCrossRef Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I. Evaluating Cinchona bark and quinine for treating and preventing malaria. J Roy Soc Med. 2017;110:73–82.PubMedCrossRef
24.
go back to reference de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countries. J Ethnopharmacol. 2008;120:302–14.PubMedCrossRef de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countries. J Ethnopharmacol. 2008;120:302–14.PubMedCrossRef
26.
go back to reference Pan S-Y, Litscher G, Gao S-H, Zhou S-F, Yu Z-L, Chen H-Q, et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complementary Altern Med. 2014;2014:525340. Pan S-Y, Litscher G, Gao S-H, Zhou S-F, Yu Z-L, Chen H-Q, et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complementary Altern Med. 2014;2014:525340.
27.
go back to reference Hoffmann KM, Herbrechter R, Ziemba PM, Lepke P, Beltrán L, Hatt H, et al. Kampo medicine: evaluation of the pharmacological activity of 121 herbal drugs on GABAA and 5-HT3A receptors. Front Pharmacol. 2016;7:219.PubMedPubMedCentralCrossRef Hoffmann KM, Herbrechter R, Ziemba PM, Lepke P, Beltrán L, Hatt H, et al. Kampo medicine: evaluation of the pharmacological activity of 121 herbal drugs on GABAA and 5-HT3A receptors. Front Pharmacol. 2016;7:219.PubMedPubMedCentralCrossRef
28.
go back to reference Chen X, Xiang L, Shi L, Li G, Yao H, Han J, et al. Identification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system. Sci Rep. 2017;7:42325.PubMedPubMedCentralCrossRef Chen X, Xiang L, Shi L, Li G, Yao H, Han J, et al. Identification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system. Sci Rep. 2017;7:42325.PubMedPubMedCentralCrossRef
29.
go back to reference Arai M, Katai S, Muramatsu S-I, Namiki T, Hanawa T, Izumi S-I. Current status of Kampo medicine curricula in all Japanese medical schools. BMC Complem Altern Med. 2012;12:207.CrossRef Arai M, Katai S, Muramatsu S-I, Namiki T, Hanawa T, Izumi S-I. Current status of Kampo medicine curricula in all Japanese medical schools. BMC Complem Altern Med. 2012;12:207.CrossRef
30.
go back to reference Yakubo S, Ito M, Ueda Y, Okamoto H, Kimura Y, Amano Y, et al. Pattern classification in Kampo medicine. Evid Based Complemen Altern Med. 2014;2014:535146.CrossRef Yakubo S, Ito M, Ueda Y, Okamoto H, Kimura Y, Amano Y, et al. Pattern classification in Kampo medicine. Evid Based Complemen Altern Med. 2014;2014:535146.CrossRef
31.
go back to reference Yoshino T, Katayama K, Horiba Y, Munakata K, Yamaguchi R, Imoto S, et al. Predicting Japanese Kampo formulas by analyzing database of medical records: a preliminary observational study. BMC Med Inform Decis Mak. 2016;16:118.PubMedPubMedCentralCrossRef Yoshino T, Katayama K, Horiba Y, Munakata K, Yamaguchi R, Imoto S, et al. Predicting Japanese Kampo formulas by analyzing database of medical records: a preliminary observational study. BMC Med Inform Decis Mak. 2016;16:118.PubMedPubMedCentralCrossRef
32.
go back to reference Motoo Y, Seki T, Tsutani K. Traditional Japanese medicine, Kampo: its history and current status. Chin J Integr Med. 2011;17:85–7.PubMedCrossRef Motoo Y, Seki T, Tsutani K. Traditional Japanese medicine, Kampo: its history and current status. Chin J Integr Med. 2011;17:85–7.PubMedCrossRef
33.
go back to reference Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, et al. Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine—the state of research and methodological suggestions for the future. Evid Based Complementary Altern Med. 2011;2011:513842. Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, et al. Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine—the state of research and methodological suggestions for the future. Evid Based Complementary Altern Med. 2011;2011:513842.
35.
go back to reference Borenfreund E, Babich H. In vitro cytotoxicity of heavy metals, acrylamide, and organotin salts to neural cells and fibroblasts. Cell Biol Toxicol. 1987;3:63–73.PubMedCrossRef Borenfreund E, Babich H. In vitro cytotoxicity of heavy metals, acrylamide, and organotin salts to neural cells and fibroblasts. Cell Biol Toxicol. 1987;3:63–73.PubMedCrossRef
37.
go back to reference Mosaddeque F, Mizukami S, Kamel MG, Teklemichael AA, Dat TV, Mizuta S, et al. Prediction model for antimalarial activities of hemozoin inhibitors by using physicochemical properties. Antimicrob Agents Chemother. 2018;62:e02424–17.PubMedPubMedCentralCrossRef Mosaddeque F, Mizukami S, Kamel MG, Teklemichael AA, Dat TV, Mizuta S, et al. Prediction model for antimalarial activities of hemozoin inhibitors by using physicochemical properties. Antimicrob Agents Chemother. 2018;62:e02424–17.PubMedPubMedCentralCrossRef
39.
go back to reference Su J, Miao Q, Miao P, Zhao Y, Zhang Y, Chen N, et al. Pharmacokinetics and brain distribution and metabolite identification of coptisine, a protoberberine alkaloid with therapeutic potential for CNS disorders, in rats. Biol Pharm Bull. 2015;38:1518–28.PubMedCrossRef Su J, Miao Q, Miao P, Zhao Y, Zhang Y, Chen N, et al. Pharmacokinetics and brain distribution and metabolite identification of coptisine, a protoberberine alkaloid with therapeutic potential for CNS disorders, in rats. Biol Pharm Bull. 2015;38:1518–28.PubMedCrossRef
40.
go back to reference Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci. 2017;42:115–28.PubMedPubMedCentral Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci. 2017;42:115–28.PubMedPubMedCentral
41.
go back to reference Cañón M, Diaz H, Olarte A. Mathematical model for the spread of drug resistance in Plasmodium falciparum parasite considering transmission conditions. J Theor Biol. 2017;435:1–11.PubMedCrossRef Cañón M, Diaz H, Olarte A. Mathematical model for the spread of drug resistance in Plasmodium falciparum parasite considering transmission conditions. J Theor Biol. 2017;435:1–11.PubMedCrossRef
42.
go back to reference Nsanzabana C, Djalle D, Guérin PJ, Ménard D, González IJ. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape. Malar J. 2018;17:75.PubMedPubMedCentralCrossRef Nsanzabana C, Djalle D, Guérin PJ, Ménard D, González IJ. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape. Malar J. 2018;17:75.PubMedPubMedCentralCrossRef
43.
go back to reference Fujii A, Okuyama T, Wakame K, Okumura T, Ikeya Y, Nishizawa M. Identification of anti-inflammatory constituents in Phellodendri cortex and Coptidis Rhizoma by monitoring the suppression of nitric oxide production. J Nat Med. 2017;71:745–56.PubMedCrossRef Fujii A, Okuyama T, Wakame K, Okumura T, Ikeya Y, Nishizawa M. Identification of anti-inflammatory constituents in Phellodendri cortex and Coptidis Rhizoma by monitoring the suppression of nitric oxide production. J Nat Med. 2017;71:745–56.PubMedCrossRef
44.
go back to reference Oshima N, Shimizu T, Narukawa Y, Hada N, Kiuchi F. Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production. J Nat Med. 2018;72:706–14.PubMedCrossRef Oshima N, Shimizu T, Narukawa Y, Hada N, Kiuchi F. Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production. J Nat Med. 2018;72:706–14.PubMedCrossRef
45.
go back to reference Chen Y, Xian Y, Lai Z, Loo S, Chan WY, Lin Z-X. Anti-inflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: implication for atopic dermatitis treatment. J Ethnopharmacol. 2016;185:41–52.PubMedCrossRef Chen Y, Xian Y, Lai Z, Loo S, Chan WY, Lin Z-X. Anti-inflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: implication for atopic dermatitis treatment. J Ethnopharmacol. 2016;185:41–52.PubMedCrossRef
46.
go back to reference Nonaka M, Murata Y, Takano R, Han Y, Kabir MHB, Kato K. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts. Malar J. 2018;17:244.PubMedPubMedCentralCrossRef Nonaka M, Murata Y, Takano R, Han Y, Kabir MHB, Kato K. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts. Malar J. 2018;17:244.PubMedPubMedCentralCrossRef
47.
go back to reference Wilson DW, Langer C, Goodman CD, McFadden GI, Beeson JG. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob Agents Chemother. 2013;57:1455–67.PubMedPubMedCentralCrossRef Wilson DW, Langer C, Goodman CD, McFadden GI, Beeson JG. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob Agents Chemother. 2013;57:1455–67.PubMedPubMedCentralCrossRef
48.
go back to reference Mahmoudvand H, Ayatollahi Mousavi SA, Sepahvand A, Sharififar F, Ezatpour B, et al. Antifungal, antileishmanial, and cytotoxicity activities of various extracts of Berberis vulgaris (Berberidaceae) and its active principle Berberine. ISRN Pharmacol. 2014;2014:602436.PubMedPubMedCentralCrossRef Mahmoudvand H, Ayatollahi Mousavi SA, Sepahvand A, Sharififar F, Ezatpour B, et al. Antifungal, antileishmanial, and cytotoxicity activities of various extracts of Berberis vulgaris (Berberidaceae) and its active principle Berberine. ISRN Pharmacol. 2014;2014:602436.PubMedPubMedCentralCrossRef
49.
go back to reference Chou H-C, Lu Y-C, Cheng C-S, Chen Y-W, Lyu P-C, Lin C-W, et al. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics. 2012;75:3158–76.PubMedCrossRef Chou H-C, Lu Y-C, Cheng C-S, Chen Y-W, Lyu P-C, Lin C-W, et al. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics. 2012;75:3158–76.PubMedCrossRef
50.
go back to reference El Khalki L, Tilaoui M, Jaafari A, Ait Mouse H, Zyad A. Studies on the dual cytotoxicity and antioxidant properties of Berberis vulgaris extracts and its main constituent berberine. Adv Pharmacol Sci. 2018;2018:3018498.PubMed El Khalki L, Tilaoui M, Jaafari A, Ait Mouse H, Zyad A. Studies on the dual cytotoxicity and antioxidant properties of Berberis vulgaris extracts and its main constituent berberine. Adv Pharmacol Sci. 2018;2018:3018498.PubMed
51.
go back to reference Han B, Jiang P, Li Z, Yu Y, Huang T, Ye X, et al. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway. Phytomedicine. 2018;48:152–60.PubMedCrossRef Han B, Jiang P, Li Z, Yu Y, Huang T, Ye X, et al. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway. Phytomedicine. 2018;48:152–60.PubMedCrossRef
52.
go back to reference Fu S, Ni S, Wang D, Hong T. Coptisine suppresses mast cell degranulation and ovalbumin-induced allergic rhinitis. Molecules. 2018;23:3039.PubMedCentralCrossRef Fu S, Ni S, Wang D, Hong T. Coptisine suppresses mast cell degranulation and ovalbumin-induced allergic rhinitis. Molecules. 2018;23:3039.PubMedCentralCrossRef
53.
go back to reference Shi L-L, Jia W-H, Zhang L, Xu C-Y, Chen X, Yin L, et al. Glucose consumption assay discovers coptisine with beneficial effect on diabetic mice. Eur J Pharmacol. 2019;859:172523.PubMedCrossRef Shi L-L, Jia W-H, Zhang L, Xu C-Y, Chen X, Yin L, et al. Glucose consumption assay discovers coptisine with beneficial effect on diabetic mice. Eur J Pharmacol. 2019;859:172523.PubMedCrossRef
54.
go back to reference Xu Z, Feng W, Shen Q, Yu N, Yu K, Wang S, Chen Z, et al. Rhizoma coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation. Aging Dis. 2017;8:760–77.PubMedPubMedCentralCrossRef Xu Z, Feng W, Shen Q, Yu N, Yu K, Wang S, Chen Z, et al. Rhizoma coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation. Aging Dis. 2017;8:760–77.PubMedPubMedCentralCrossRef
55.
go back to reference Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41–58.PubMedCrossRef Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41–58.PubMedCrossRef
56.
go back to reference Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med. 2017;23:405–8.PubMedPubMedCentralCrossRef Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med. 2017;23:405–8.PubMedPubMedCentralCrossRef
57.
go back to reference Rabinovich NR. Ivermectin: repurposing an old drug to complement malaria vector control. Lancet Infect Dis. 2018;18:584–5.PubMedCrossRef Rabinovich NR. Ivermectin: repurposing an old drug to complement malaria vector control. Lancet Infect Dis. 2018;18:584–5.PubMedCrossRef
Metadata
Title
Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds
Authors
Awet Alem Teklemichael
Shusaku Mizukami
Kazufumi Toume
Farhana Mosaddeque
Mohamed Gomaa Kamel
Osamu Kaneko
Katsuko Komatsu
Juntra Karbwang
Nguyen Tien Huy
Kenji Hirayama
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03273-x

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.